| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000017686 |
| Receipt No. | R000020499 |
| Official scientific title of the study | Study about hyperglycemia inhibiting effect after meal of Agave Syrup. |
| Date of disclosure of the study information | 2015/06/01 |
| Last modified on | 2016/05/26 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study about hyperglycemia inhibiting effect after meal of Agave Syrup. | |
| Title of the study (Brief title) | GI of Agave Syrup | |
| Region |
|
|
| Condition | ||
| Condition | Type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | GI value of agave nectar is said to 21, which is an inspection values in Canada. In the study, the research subject is the Japanese juvenile adult women, again to confirm whether there is a postprandial hyperglycemia inhibitory effect on agave nectar, Japanese cuisine is prepared with a sweetener, which is commonly used in Japan , go also examined the presence of postprandial hyperglycemia suppression effect.
Japanese cuisine is characterized of using a lot of sweetener in comparison with the other dishes. Its Japanese The use of agave nectar is low GI for cooking, not only diet for type 2 diabetes, it is considered useful for a wide maintenance and improvement of public health. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 12 days |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Glucose 50g intake three times
Agave nectar intake three times Japanese cuisine eating 3 times Japanese cuisine eating three times where the flavored with agave nectar |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | BMI30 below | |||
| Key exclusion criteria | Impaired glucose tolerance | |||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | AKIYAMA Kumiko |
| Organization | Showa Women's University |
| Division name | Department of Human health and Design |
| Address | 1-7-57 Taishido, Setagaya-ku, Tokyo, Japan |
| TEL | +81(3)3411-6237 |
| akiyama@swu.ac.jp | |
| Public contact | |
| Name of contact person | AKIYAMA Kumiko |
| Organization | Showa Women's University |
| Division name | Department of Human health and Design |
| Address | 1-7-57 Taishido, Setagaya-ku, Tokyo, Japan |
| TEL | +81(3)3411-6237 |
| Homepage URL | |
| akiyama@swu.ac.jp | |
| Sponsor | |
| Institute | Showa Women's University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Showa Women's University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 昭和女子大学 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020499 |